In this article, Cerba dives into CAR+ T-cell therapy, from patient treatment to solutions for minimal residual disease (MRD) ...

The next-generation sequencing market valued at US$ 13.92 billion in 2023, is forecasted to grow at a robust CAGR of 11.0%, ...

Discover the top genomics startups revolutionizing genome sequencing technologies to enhance disease prevention and treatment ...

Datar Cancer Genetics (DCG) has launched Exacta AI, a next generation multi-analyte AI-driven platform providing optimized treatment options for cancer patients who have exhausted the standard options ...

Authenticated data presented in the Life science tools market report is based on findings of extensive primary and secondary research.

The life sciences business is characterized by demands in preclinical discovery and research. Revvity has been able to offer a more complete workflow to customers in this segment, building off the ...

Now in the market for the first time, the single-flow-cell NovaSeq X Sequencing System ... Geneviève DonPierre, team leader of NGS Sequencing at Génome Québec, stated, "The increased yield ...

Learn more about whether Qiagen N.V. or Repligen Corporation is a better investment based on AAII's A+ Investor grades, which ...